174 related articles for article (PubMed ID: 16409121)
1. Adeno-associated virus types 5 and 6 use distinct receptors for cell entry.
Seiler MP; Miller AD; Zabner J; Halbert CL
Hum Gene Ther; 2006 Jan; 17(1):10-9. PubMed ID: 16409121
[TBL] [Abstract][Full Text] [Related]
2. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors.
Halbert CL; Allen JM; Miller AD
J Virol; 2001 Jul; 75(14):6615-24. PubMed ID: 11413329
[TBL] [Abstract][Full Text] [Related]
3. Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes.
Wu Z; Asokan A; Grieger JC; Govindasamy L; Agbandje-McKenna M; Samulski RJ
J Virol; 2006 Nov; 80(22):11393-7. PubMed ID: 16943302
[TBL] [Abstract][Full Text] [Related]
4. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes.
Halbert CL; Rutledge EA; Allen JM; Russell DW; Miller AD
J Virol; 2000 Feb; 74(3):1524-32. PubMed ID: 10627564
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity.
Kaludov N; Brown KE; Walters RW; Zabner J; Chiorini JA
J Virol; 2001 Aug; 75(15):6884-93. PubMed ID: 11435568
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site.
Huang LY; Patel A; Ng R; Miller EB; Halder S; McKenna R; Asokan A; Agbandje-McKenna M
J Virol; 2016 Jun; 90(11):5219-5230. PubMed ID: 26962225
[TBL] [Abstract][Full Text] [Related]
7. Virus-mediated transduction of murine retina with adeno-associated virus: effects of viral capsid and genome size.
Yang GS; Schmidt M; Yan Z; Lindbloom JD; Harding TC; Donahue BA; Engelhardt JF; Kotin R; Davidson BL
J Virol; 2002 Aug; 76(15):7651-60. PubMed ID: 12097579
[TBL] [Abstract][Full Text] [Related]
8. Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro.
Limberis MP; Vandenberghe LH; Zhang L; Pickles RJ; Wilson JM
Mol Ther; 2009 Feb; 17(2):294-301. PubMed ID: 19066597
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors.
Halbert CL; Miller AD; McNamara S; Emerson J; Gibson RL; Ramsey B; Aitken ML
Hum Gene Ther; 2006 Apr; 17(4):440-7. PubMed ID: 16610931
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer.
Pandya M; Britt K; Hoffman B; Ling C; Aslanidi GV
J Immunother; 2015 Sep; 38(7):292-8. PubMed ID: 26261893
[TBL] [Abstract][Full Text] [Related]
11. Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene.
Halbert CL; Allen JM; Miller AD
Nat Biotechnol; 2002 Jul; 20(7):697-701. PubMed ID: 12089554
[TBL] [Abstract][Full Text] [Related]
12. Enhanced transduction of mouse salivary glands with AAV5-based vectors.
Katano H; Kok MR; Cotrim AP; Yamano S; Schmidt M; Afione S; Baum BJ; Chiorini JA
Gene Ther; 2006 Apr; 13(7):594-601. PubMed ID: 16341060
[TBL] [Abstract][Full Text] [Related]
13. Lack of repeat transduction by recombinant adeno-associated virus type 5/5 vectors in the mouse airway.
Sumner-Jones SG; Gill DR; Hyde SC
J Virol; 2007 Nov; 81(22):12360-7. PubMed ID: 17855531
[TBL] [Abstract][Full Text] [Related]
14. Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6.
Wu Z; Miller E; Agbandje-McKenna M; Samulski RJ
J Virol; 2006 Sep; 80(18):9093-103. PubMed ID: 16940521
[TBL] [Abstract][Full Text] [Related]
15. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
[TBL] [Abstract][Full Text] [Related]
16. Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors.
Sandalon Z; Bruckheimer EM; Lustig KH; Rogers LC; Peluso RW; Burstein H
J Virol; 2004 Nov; 78(22):12355-65. PubMed ID: 15507622
[TBL] [Abstract][Full Text] [Related]
17. Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human glioblastoma multiforme xenografts.
Huszthy PC; Svendsen A; Wilson JM; Kotin RM; Lønning PE; Bjerkvig R; Hoover F
Hum Gene Ther; 2005 Mar; 16(3):381-92. PubMed ID: 15812233
[TBL] [Abstract][Full Text] [Related]
18. Genetic Modification of the AAV5 Capsid with Lysine Residues Results in a Lung-Tropic Liver-Detargeted Gene Transfer Vector.
Stiles KM; Frenk EZ; Kaminsky SM; Crystal RG
Hum Gene Ther; 2022 Feb; 33(3-4):148-154. PubMed ID: 35018834
[TBL] [Abstract][Full Text] [Related]
19. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
Shi W; Arnold GS; Bartlett JS
Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
[TBL] [Abstract][Full Text] [Related]
20. Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells.
Sayroo R; Nolasco D; Yin Z; Colon-Cortes Y; Pandya M; Ling C; Aslanidi G
Gene Ther; 2016 Jan; 23(1):18-25. PubMed ID: 26270885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
